ArticleClinical cancer research : an official journal of the American Association for Cancer Research2023

Duvelisib Eliminates CLL B Cells, Impairs CLL-Supporting Cells, and Overcomes Ibrutinib Resistance in a Xenograft Model.

Shih-Shih Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.